Ameritas Investment Partners’s Kite Pharma, Inc. KITE Stock Holding History

Ameritas Investment Partners’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,207	Closed	-$748K	–	3015
2017 Q3	$748K	Sell	4,207 -85	-2%	-$11.8K	0.04%	642
2017 Q2	$445K	Buy	4,292 +638	+17%	+$52.1K	0.02%	782
2017 Q1	$287K	Buy	+3,654	New	+$226K	0.01%	894
2016 Q2	–	Sell	-5,200	Closed	-$238K	–	1214
2016 Q1	$238K	Sell	5,200 -8,200	-61%	-$397K	0.02%	882
2015 Q4	$825K	Hold	13,400	–	–	0.06%	353
2015 Q3	$746K	Hold	13,400	–	–	0.05%	366
2015 Q2	$816K	Buy	13,400 +3,000	+29%	+$171K	0.05%	365
2015 Q1	$599K	Buy	+10,400	New	+$697K	0.04%	513

Ameritas Investment Partners's KITE Position: Q4 2017 in Review

Ameritas Investment Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 4,207 shares — an estimated $748K sold.

Ameritas Investment Partners first reported a position in KITE in Q1 2015 and held it in 8 quarters. The position peaked at $825K in Q4 2015. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Ameritas Investment Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Ameritas Investment Partners sold 4,207 Kite Pharma, Inc. shares in Q4 2017, an estimated $748K.
Ameritas Investment Partners first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 8 quarters.
Ameritas Investment Partners's Kite Pharma, Inc. position peaked at $825K in Q4 2015.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Ameritas Investment Partners's 13F filing for Q4 2017, filed 14 Feb 2018.